For research papers The BMJ has fully open peer review. This means that accepted research papers published from early 2015 onwards usually have their prepublication history posted alongside them on ...

Common drugs taken by up to 10million Americans may lower the risk of stroke in women with chronic migraines, a study from ...

A new review from the Cochrane Database of Systematic Reviews confirms that antidepressants can effectively reduce symptoms ...

Scientists have pinpointed a brain circuit that, when activated, reduces anxiety without impairing memory. Using ...

A Cochrane review has concluded that antidepressants are more effective than placebo in reducing the symptoms of generalised anxiety disorder (GAD) in the short term.1 The National Institute for ...

Cornell researchers have identified a specific brain circuit that could lead to anxiety treatments without cognitive side ...

Repurposed Drugs is under clinical development by Luminous Mind and currently in Phase I for Anxiety Disorders. According to GlobalData, Phase I drugs for Anxiety Disorders have a 69% phase transition ...

The prevalence of diagnosed disorders from recurrent use of sedative, hypnotic and antianxiety medications in adolescents and young adults has increased sharply since 2001, according to Rutgers Health ...

Teens and young adults with anxiety, ADHD, or sleep disorders were more likely to have a diagnosis of addiction to sedatives ...

Fasedienol is under clinical development by VistaGen Therapeutics and currently in Phase III for Anxiety Disorders. According to GlobalData, Phase III drugs for Anxiety Disorders have a 39% phase ...

A young woman who took her own life after her mental health team refused to prescribe ‘”effective” medication was treated like a “child asking for sweets”, her father has said.